RESUMO
Streptococcus agalactiae is one of the main aetiological agents in large-scale mortalities of tilapia, having caused major economic losses to the aquaculture industry in recent years. This study describes the isolation and identification of the bacteria from cage-cultured Etroplus suratensis that experienced moderate to severe mortalities in Kerala, India. Gram-positive, catalase-negative S. agalactiae was identified from brain, eye and liver of the fish by antigen grouping and 16S rDNA sequencing. Multiplex PCR confirmed that the isolate belonged to capsular serotype Ia. Antibiotic susceptibility tests showed that the isolate was resistant to methicillin, vancomycin, tetracycline, kanamycin, streptomycin, ampicillin, oxacillin and amikacin. Histological sections of the infected E. suratensis brain revealed infiltration of inflammatory cells, vacuolation and meningitis. This report is the first description of S. agalactiae as a primary pathogen causing mortalities in E. suratensis culture in Kerala.